These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19346460)

  • 1. How does Viagra protect the ischemic heart?
    Xia Y
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1209-10. PubMed ID: 19346460
    [No Abstract]   [Full Text] [Related]  

  • 2. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
    Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
    Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats.
    Choi DE; Jeong JY; Lim BJ; Chung S; Chang YK; Lee SJ; Na KR; Kim SY; Shin YT; Lee KW
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F362-70. PubMed ID: 19474186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.
    Kukreja RC
    Br J Pharmacol; 2007 Mar; 150(5):538-40. PubMed ID: 17245364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and role of myocyte cyclic GMP-dependent protein kinase-1.
    Kass DA; Takimoto E
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):E98; author reply E99. PubMed ID: 20498039
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
    Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
    Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.
    Das A; Xi L; Kukreja RC
    J Biol Chem; 2005 Apr; 280(13):12944-55. PubMed ID: 15668244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway.
    Hsu S; Nagayama T; Koitabashi N; Zhang M; Zhou L; Bedja D; Gabrielson KL; Molkentin JD; Kass DA; Takimoto E
    Cardiovasc Res; 2009 Feb; 81(2):301-9. PubMed ID: 19029137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway.
    Pyriochou A; Zhou Z; Koika V; Petrou C; Cordopatis P; Sessa WC; Papapetropoulos A
    J Cell Physiol; 2007 Apr; 211(1):197-204. PubMed ID: 17226792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
    Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are the mechanisms for NO-dependent vascular remodeling different from vasorelaxation in vivo?
    Schleicher M; Sessa WC
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1207-8. PubMed ID: 18565841
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
    Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y
    Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
    Salloum F; Yin C; Xi L; Kukreja RC
    Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase-5 inhibition abolishes neuron apoptosis induced by chronic hypoxia independently of hypoxia-inducible factor-1alpha signaling.
    Caretti A; Bianciardi P; Ronchi R; Fantacci M; Guazzi M; Samaja M
    Exp Biol Med (Maywood); 2008 Oct; 233(10):1222-30. PubMed ID: 18641057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice.
    Hoke NN; Salloum FN; Kass DA; Das A; Kukreja RC
    Stem Cells; 2012 Feb; 30(2):326-35. PubMed ID: 22102597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway.
    Chau VQ; Salloum FN; Hoke NN; Abbate A; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2272-9. PubMed ID: 21398594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressure-overload magnitude-dependence of the anti-hypertrophic efficacy of PDE5A inhibition.
    Nagayama T; Hsu S; Zhang M; Koitabashi N; Bedja D; Gabrielson KL; Takimoto E; Kass DA
    J Mol Cell Cardiol; 2009 Apr; 46(4):560-7. PubMed ID: 19159628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased activity of the Na+/H+ exchanger by phosphodiesterase 5A inhibition is attributed to an increase in protein phosphatase activity.
    Yeves AM; Garciarena CD; Nolly MB; Chiappe de Cingolani GE; Cingolani HE; Ennis IL
    Hypertension; 2010 Oct; 56(4):690-5. PubMed ID: 20713918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.